Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
648.93
534.55
463.46
372.62
458.95
391.89
315.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
648.93
534.55
463.46
372.62
458.95
391.89
315.48
Raw Material Cost
392.41
384.33
327.80
224.35
347.73
226.71
198.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-27.85
-95.18
-64.22
24.98
-105.38
17.93
-10.63
Employee Cost
58.49
53.45
42.21
39.26
37.23
28.80
29.14
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
67.26
60.94
51.54
40.60
43.80
27.99
24.94
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
27.24
32.82
23.13
12.17
17.29
10.45
8.33
Total Expenditure (Excl Depreciation)
517.55
436.36
380.46
341.36
340.67
311.88
249.83
Operating Profit (PBDIT) excl Other Income
131.38
98.19
83.00
31.26
118.28
80.01
65.65
Other Income
5.78
4.80
2.81
3.62
4.77
2.17
2.02
Operating Profit (PBDIT)
137.16
102.99
85.81
34.88
123.05
82.18
67.67
Interest
17.80
13.47
17.84
16.03
14.53
8.61
9.34
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
119.36
89.52
67.97
18.85
108.52
73.57
58.33
Depreciation
29.79
25.70
23.60
24.15
24.18
16.75
16.07
Profit Before Tax
89.57
63.81
44.37
-5.28
84.34
56.81
42.26
Tax
22.54
16.50
11.23
-1.10
25.86
18.05
15.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
67.03
47.32
33.15
-4.18
58.48
38.75
26.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
67.03
47.32
33.15
-4.18
58.48
38.75
26.53
Share in Profit of Associates
2.24
1.50
-0.60
-6.83
-2.93
0.64
-1.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
69.27
48.82
32.55
-11.02
55.55
39.39
25.27
Equity Capital
9.37
8.47
8.47
8.47
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
2.59
2.15
1.36
0.44
1.07
2.53
0.9
Operating Profit Margin (Excl OI)
20.25%
18.37%
17.91%
8.39%
25.77%
20.42%
20.81%
Gross Profit Margin
18.39%
16.75%
14.67%
5.06%
23.65%
18.77%
18.49%
PAT Margin
10.33%
8.85%
7.15%
-1.12%
12.74%
9.89%
8.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 21.40% vs 15.34% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 41.89% vs 49.98% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 33.80% vs 18.30% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 32.15% vs -24.50% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of SMS Pharma. With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
648.93
0
648.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
648.93
0
648.93
Raw Material Cost
392.41
0
392.41
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-27.85
0
-27.85
Employee Cost
58.49
0
58.49
Power Cost
0.00
0
0.00
Manufacturing Expenses
67.26
0
67.26
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
27.24
0.00
27.24
Total Expenditure (Excl Depreciation)
517.55
0
517.55
Operating Profit (PBDIT) excl Other Income
131.38
0.00
131.38
Other Income
5.78
0
5.78
Operating Profit (PBDIT)
137.16
0
137.16
Interest
17.80
0
17.80
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
119.36
0
119.36
Depreciation
29.79
0
29.79
Profit Before Tax
89.57
0
89.57
Tax
22.54
0
22.54
Provisions and contingencies
0.00
0
0.00
Profit After Tax
67.03
0
67.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
67.03
0
67.03
Share in Profit of Associates
2.24
0
2.24
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
69.27
0
69.27
Equity Capital
9.37
0
9.37
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
18.39%
0%
0.00
18.39%
PAT Margin
10.33%
0%
0.00
10.33%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 648.93 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 21.40% vs 15.34% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 69.27 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 41.89% vs 49.98% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 131.38 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 33.80% vs 18.30% in Dec 2024
Nine Monthly - Interest
Interest 17.80 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 32.15% vs -24.50% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.25%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
